JP6199050B2 - ＧＰＩｂ−フォン・ヴィレブランド因子相互作用の機能障害を有する試料を見出すためのスクリーニング方法 - Google Patents

ＧＰＩｂ−フォン・ヴィレブランド因子相互作用の機能障害を有する試料を見出すためのスクリーニング方法 Download PDF

Info

Publication number
JP6199050B2
JP6199050B2 JP2013043157A JP2013043157A JP6199050B2 JP 6199050 B2 JP6199050 B2 JP 6199050B2 JP 2013043157 A JP2013043157 A JP 2013043157A JP 2013043157 A JP2013043157 A JP 2013043157A JP 6199050 B2 JP6199050 B2 JP 6199050B2
Authority
JP
Japan
Prior art keywords
vwf
protein
gpibα
solid phase
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013043157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013186124A (ja
JP2013186124A5 (enExample
Inventor
パツケ ユルゲン
パツケ ユルゲン
Original Assignee
シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング
シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング, シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング filed Critical シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング
Publication of JP2013186124A publication Critical patent/JP2013186124A/ja
Publication of JP2013186124A5 publication Critical patent/JP2013186124A5/ja
Application granted granted Critical
Publication of JP6199050B2 publication Critical patent/JP6199050B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2013043157A 2012-03-05 2013-03-05 ＧＰＩｂ−フォン・ヴィレブランド因子相互作用の機能障害を有する試料を見出すためのスクリーニング方法 Active JP6199050B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12158022.9A EP2637024A1 (de) 2012-03-05 2012-03-05 Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion
EP12158022.9 2012-03-05

Publications (3)

Publication Number Publication Date
JP2013186124A JP2013186124A (ja) 2013-09-19
JP2013186124A5 JP2013186124A5 (enExample) 2016-03-03
JP6199050B2 true JP6199050B2 (ja) 2017-09-20

Family

ID=47722189

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013043157A Active JP6199050B2 (ja) 2012-03-05 2013-03-05 ＧＰＩｂ−フォン・ヴィレブランド因子相互作用の機能障害を有する試料を見出すためのスクリーニング方法

Country Status (4)

Country Link
US (1) US9766234B2 (enExample)
EP (2) EP2637024A1 (enExample)
JP (1) JP6199050B2 (enExample)
ES (1) ES2575778T3 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007031708A1 (de) * 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
EP2637024A1 (de) 2012-03-05 2013-09-11 Siemens Healthcare Diagnostics Products GmbH Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion
EP2919013B1 (de) 2014-03-11 2016-11-02 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Detektion von Modulatoren der GPIb-Thrombin-Interaktion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69940058D1 (de) * 1998-04-23 2009-01-22 Ajinomoto Kk Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin
ES2358576T3 (es) 1999-07-05 2011-05-11 K.U. LEUVEN RESEARCH & DEVELOPMENT Detección de la actividad del factor de von-willebrand (vwf).
DE102006019520A1 (de) * 2006-04-27 2007-11-08 Dade Behring Marburg Gmbh Verfahren zur Bestimmung hoher Ristocetin-Kofaktor-Aktivitäten des von-Willebrand-Faktors
DE102007031708A1 (de) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
EP2193373A4 (en) 2007-08-23 2010-07-28 Bloodct Of Wisconsin Inc METHODS AND KITS FOR MEASURING VON WILLEBRAND FACTOR
EP2637024A1 (de) 2012-03-05 2013-09-11 Siemens Healthcare Diagnostics Products GmbH Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion

Also Published As

Publication number Publication date
JP2013186124A (ja) 2013-09-19
ES2575778T3 (es) 2016-07-01
EP2637024A1 (de) 2013-09-11
EP2637025B1 (de) 2016-04-13
US9766234B2 (en) 2017-09-19
EP2637025A3 (de) 2013-11-20
EP2637025A2 (de) 2013-09-11
US20130230868A1 (en) 2013-09-05

Similar Documents

Publication Publication Date Title
JP5745270B2 (ja) リストセチン非存在下のフォンビルブラント因子活性の測定方法及びａｄａｍｔｓ−１３プロテアーゼの測定方法
Coller Interaction of normal, thrombasthenic and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia
Martin et al. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibα
US9851367B2 (en) Method of detection of platelet-activating antibodies that cause heparin-induced thrombocytopenia/thrombosis
Madabhushi et al. von Willebrand factor (VWF) propeptide binding to VWF D′ D3 domain attenuates platelet activation and adhesion
JP2014112114A (ja) 血小板凝集アッセイ
JP6199050B2 (ja) ＧＰＩｂ−フォン・ヴィレブランド因子相互作用の機能障害を有する試料を見出すためのスクリーニング方法
Beer et al. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction
Mondoro et al. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor
US11067572B2 (en) Methods and assays for factor VIII activity
JP6418986B2 (ja) ＧＰＩｂ−トロンビン相互作用のモジュレーターを検出するための方法
Hayward et al. Human platelets contain forms of factor V in disulfide-linkage with multimerin
Kraus et al. Influence of Acute Phase Proteins on Neutrophil Function In Vitro
US20130203077A1 (en) Quantitation of urinary tissue factor for the diagnosis and screening of cancer
CA3013662A1 (en) Method of separating factor viii from blood products
EP3433619A1 (en) Free functional annexin levels in plasma as a biomarker of cardiovascular risk

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160119

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20161013

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161025

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170123

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170404

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170725

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170823

R150 Certificate of patent or registration of utility model

Ref document number: 6199050

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250